Despite being the most common pancreatic cancer, pancreatic ductal adenocarcinoma (PDAC) is notoriously difficult to treat, while new research shows treatment and diagnosis could benefit from ...
Given that more than 40% of patients do not receive second-line therapy in PDAC because of rapidly progressive disease, 4 an increased emphasis is needed in delivering optimal treatment in the ...
(A) Schematic workflow of sample collection for further single-cell RNA sequencing. (B) The hematoxylin and eosin staining and immunohistochemistry staining of tumor sample from P6. (C) UMAP plots of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback